Lymphoma Cancer Breakthrough News
|
|
Nov 26, 2008
Tumor Surroundings Influence Survival in Diffuse
Large-B-Cell Lymphoma |
|
|
By Michael Smith,
North American Correspondent, MedPage Today
BETHESDA, Md., Nov. 26
-- Survival after treatment for diffuse large-B-cell
lymphoma is influenced not only by the cancer, but
by the tumor microenvironment, researchers here
said. <READ
MORE> |
|
|
|
|
Mar. 20, 2008
FDA Okays Bendamustine
(Treanda) for CLL |
|
|
By Todd Neale, Staff
Writer, MedPage Today
FRAZER, Pa., March 20
-- The FDA has approved bendamustine (Treanda) to
treat chronic lymphocytic leukemia, announced
Cephalon, U.S. developer of the drug. <READ
MORE> |
|
|
|
|
Mar. 13, 2008
Radioimmunotherapy After Chemotherapy Effective for
Non-Hodgkin Lymphoma |
|
|
By Judith Groch,
Senior Writer, MedPage Today
BOLOGNA, Italy, March
13 -- For untreated follicular non-Hodgkin lymphoma,
adding the radioactive drug yttrium-90 ibritumomab
tiuxetan to standard chemotherapy is safe and
effective as frontline therapy, a phase II trial
found. <READ
MORE> |
|
|
|
|
Feb. 1, 2008
High-Dose Methotrexate
Prolongs Life in Brain Lymphomas |
|
|
By Judith Groch,
Senior Writer, MedPage Today
BOSTON, Feb. 1 -- After nearly seven years, five of
12 patients maintained a complete response to
treatment with high-dose methotrexate alone for a
primary central nervous system lymphoma. <READ
MORE> |
|
|
|
|
Jan. 15,
2008
Rituximab Plus CHOP Boosts Survival in Older
Lymphoma Patients |
|
|
By Charles Bankhead,
Staff Writer, MedPage Today
HOMBURG, Germany, Jan.
15 -- Older patients with aggressive B-cell
lymphomas had significantly better outcomes when
rituximab (Rituxan), the anti-CD20 antibody, was
added to CHOP chemotherapy, researchers here found. <READ
MORE> |
|
|
|
|
Dec. 10, 2007
ASH: Radioimmunotherapeutic Consolidation a Plus for
Follicular Lymphoma |
|
|
By Charles Bankhead,
Staff Writer, MedPage Today
ATLANTA, Dec. 10 --
For advanced follicular lymphoma, consolidation of
first remission with radioimmunotherapy
significantly prolonged progression-free survival,
showed early results of a multicenter clinical
trial. <READ
MORE> |
|
|
|
|
Dec. 10, 2007
ASH: Intensified
Immunochemotherapy Offers Mantle Cell Lymphoma Cure
Potential |
|
|
By Charles Bankhead,
Staff Writer, MedPage Today
ATLANTA, Dec. 10 -- An
intensive immunochemotherapy regimen may be curative
for some patients with mantle cell lymphoma, a
Nordic research team said here. <READ
MORE> |
|
|
|
|
Oct
20, 2007
Webcast of Presentation at "Lymphoma & Myeloma 2007"
held in New York, NY. |
|
|
By
Ruben Niesvizky,
MD
Emerging therapeutic
strategies for multiple myeloma: Proteasome
inhibitors and immunomodulators
<CLICK
HERE TO VIEW WEBCAST> |
|
|
|
|
Oct
20, 2007
Webcast of Presentation at "Lymphoma & Myeloma 2007"
held in New York, NY. |
|
|
By David G. Maloney, MD, PhD
Frontline management
of follicular non-Hodgkin lymphoma (NHL): Novel
anti-CD20 therapies
<CLICK
HERE TO VIEW WEBCAST> |
|
|
|
|
Oct
20, 2007
Webcast of Presentation at "Lymphoma & Myeloma 2007"
held in New York, NY. |
|
|
By John P. Leonard, MD
Novel therapeutic
options for mantle cell lymphoma
<CLICK
HERE TO VIEW WEBCAST> |
|
|
|
|
|
|
|
|
:: 12 Element Approach :: |
 |
|
 |
 |
Explore
and supplement your therapy with ICare's
unique 12-Element approach to Patient
Survival. |
|
 |
 |
|
:: Breakthrough News :: |
 |
|
 |
 |
Breaking
news on research for gentler, more
effective therapies and information on
lifesaving treatment options. |
|
|
|
|
|
:: ICare Bulletin Board :: |
 |
|
 |
 |
View
pertinent information regarding meetings
and events pertaining to cancer
patients. This is also a resource for
contacting other patients about
information and treatment options.
|
|
|
|
|
|
|
